石四药集团港股通空最新回购 (2026-05-21) 官网 ( 02005.hk)	市盈率	14.61	市净率	0.94	股息率	3.43% (静3.43%)	上市时间2005-12-20股价2.33港币涨跌幅1.30%成交金额968.03万港币换手率0.14%市值68.76亿港币H股市值68.76亿港币总股本29.51亿H股本29.51亿每手股数2,000上市至今年化投资收益率3.87%港股通持仓占H股比例19.11% (13.14亿港币2026-07-08) 累计做空占H股比例4.88% (3.30亿港币2026-07-03)
所属三级行业药品 (恒生)	市盈率	27.74	市净率	2.49	股息率	1.37% (静1.36%)	恒生:医疗保健业药品及生物科技药品
所属指数指数纳入纳出	恒生港股通创新药指数 (0.36%) 恒生综合小型股指数 (0.21%) 恒生医疗保健指数 (0.18%) 恒生创新药指数 (0.13%) 恒生综合中小型股指数 (0.05%) 港股通价值策略 (0.02%) (共6个)
备注 (12):	双击编辑备注

发表讨论

石四药集团(02005) - 历史董事名单

#	姓名	职衔	职位	委任日期	辞任日期
1	姜廣策	Independent Non Executive Director		2023-01-01	--
2	周興揚	Executive Director		2021-08-27	--
3	孟國	Executive Director		2021-08-27	--
4	馮昊	Non Executive Director		2017-11-24	2023-11-01
5	蘇學軍	Executive Director		2014-12-15	--
6	高淑平	Executive Director		2009-07-29	2012-12-17
7	包樂源	Executive Director		2008-09-01	2012-12-17
8	曲繼廣	Executive Director	CEO	2007-07-26	--
9	王亦兵	Independent Non Executive Director		2007-07-26	--
10	段偉	Executive Director		2007-07-26	2014-12-16
11	張桂馥	Executive Director		2007-07-26	2012-04-05
12	王志忠	Executive Director		2007-07-26	2009-07-29
13	王憲軍	Executive Director		2006-09-25	2021-08-27
14	周國偉	Independent Non Executive Director - A/F		2005-10-16	--
15	梁創順	Independent Non Executive Director		2005-10-16	2023-05-19
16	曲繼廣	Independent Non Executive Director		2005-10-16	2007-07-26
17	吳秦	Executive Director	Chairman	2004-12-27	2014-06-04
18	謝云峰	Executive Director		2004-12-27	2014-06-04
19	黃朝	Executive Director		2004-12-27	2012-12-17
20	劉志勇	Non Executive Director		2004-12-27	2011-10-17
21	孫幸來	Executive Director		2004-12-27	2011-07-29
22	烏志鴻	Executive Director		2004-12-27	2008-05-30